Cargando…

BRAF Mutations in Colorectal Liver Metastases: Prognostic Implications and Potential Therapeutic Strategies

SIMPLE SUMMARY: In this literature review, we investigated the relationship between BRAF mutation and prognosis in patients with colorectal cancer liver metastases. We also investigated factors affecting the prognosis of patients with BRAF mutations and summarized the latest research on targeted the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Pei-Pei, Lin, Chen, Wang, Jane, Margonis, Georgios Antonios, Wu, Bin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454989/ https://www.ncbi.nlm.nih.gov/pubmed/36077604 http://dx.doi.org/10.3390/cancers14174067

Ejemplares similares

Prognostic and Therapeutic Implications of Tumor Biology in Colorectal Liver Metastases
por: Kamphues, Carsten, et al.
Publicado: (2021)

Is Laterality Prognostic in Resected KRAS-Mutated Colorectal Liver Metastases? A Systematic Review and Meta-Analysis
por: Belias, Michail, et al.
Publicado: (2022)

Gene Alterations, Mediators, and Artificial Intelligence in Colorectal Liver Metastases
por: Wagner, Doris, et al.
Publicado: (2022)

Precision surgery for colorectal liver metastases: Current knowledge and future perspectives
por: Margonis, Georgios Antonios, et al.
Publicado: (2022)

Staged or Simultaneous Surgery for Colon or Rectal Cancer with Synchronous Liver Metastases: Implications for Study Design and Clinical Endpoints
por: Yaqub, Sheraz, et al.
Publicado: (2023)

The implication of BRAF mutation in advanced colorectal cancer
por: O’Riordan, Emma, et al.
Publicado: (2021)

Is prognosis uniformly excellent in patients with stage II MSI-high colon cancer?
por: Wang, Jane, et al.
Publicado: (2022)

Prognostic Impact of BRAF and KRAS Mutation in Patients with Colorectal and Appendiceal Peritoneal Metastases Scheduled for CRS and HIPEC
por: Graf, Wilhelm, et al.
Publicado: (2019)

Genomic and prognostic heterogeneity among RAS/BRAF (V600E)/TP53 co‐mutated resectable colorectal liver metastases
por: Berg, Kaja C. G., et al.
Publicado: (2021)

Resectability and resection rates of colorectal liver metastases according to RAS and BRAF mutational status: prospective study
por: Uutela, Aki, et al.
Publicado: (2022)

Clinical implications of BRAF mutation test in colorectal cancer
por: Mojarad, Ehsan Nazemalhosseini, et al.
Publicado: (2013)

Prognostic factors of BRAF V600E colorectal cancer with liver metastases: a retrospective multicentric study
por: Javed, Sahir, et al.
Publicado: (2022)

Prognostic value of the combination of microsatellite instability and BRAF mutation in colorectal cancer
por: Yang, Yingchi, et al.
Publicado: (2018)

BRAF Mutation in Colorectal Cancers: From Prognostic Marker to Targetable Mutation
por: Nakayama, Izuma, et al.
Publicado: (2020)

KRAS mutation in lung metastases from colorectal cancer: prognostic implications
por: Ghidini, Michele, et al.
Publicado: (2015)

BRAF and RAS mutations as prognostic factors in metastatic colorectal cancer patients undergoing liver resection
por: Schirripa, M, et al.
Publicado: (2015)

Current Therapeutic Strategies in BRAF-Mutant Metastatic Colorectal Cancer
por: Grassi, Elisa, et al.
Publicado: (2021)

Therapeutic strategies for synchronous and multiple liver metastases from colorectal cancer
por: Osada, Shinji, et al.
Publicado: (2012)

Prognostic factors and therapeutic effects of different treatment modalities for colorectal cancer liver metastases
por: Ma, Zuo-Hong, et al.
Publicado: (2020)

Are KRAS/BRAF Mutations Potent Prognostic and/or Predictive Biomarkers in Colorectal Cancers?
por: Yokota, Tomoya
Publicado: (2012)

Mutation patterns and prognostic analysis of BRAF/KRAS/PIK3CA in colorectal cancer
por: Wang, Chengfeng, et al.
Publicado: (2022)

Molecular Heterogeneity in BRAF-Mutant Gliomas: Diagnostic, Prognostic, and Therapeutic Implications
por: Lhermitte, Benoit, et al.
Publicado: (2023)

The Prognostic Significance of Lymphatics in Colorectal Liver Metastases
por: Muralidharan, Vijayaragavan, et al.
Publicado: (2014)

Primary Tumor Sidedness, RAS and BRAF Mutations and MSI Status as Prognostic Factors in Patients with Colorectal Liver Metastases Treated with Surgery and Thermal Ablation: Results from the Amsterdam Colorectal Liver Met Registry (AmCORE)
por: Dijkstra, Madelon, et al.
Publicado: (2021)

BRAF Mutations in Melanoma: Biological Aspects, Therapeutic Implications, and Circulating Biomarkers
por: Castellani, Giorgia, et al.
Publicado: (2023)

Surgical Management of Colorectal Liver Metastases: Prognostic Indicators and the Impact of RAS Mutation Status
por: Wei, Steven H., et al.
Publicado: (2015)

BRAF mutation is a powerful prognostic factor in advanced and recurrent colorectal cancer
por: Yokota, T, et al.
Publicado: (2011)

Context-dependent interpretation of the prognostic value of BRAF and KRAS mutations in colorectal cancer
por: Popovici, Vlad, et al.
Publicado: (2013)

The prognostic significance of KRAS and BRAF mutation status in Korean colorectal cancer patients
por: Won, Daeyoun David, et al.
Publicado: (2017)

BRAF Mutation in Colorectal Cancer: An Update
por: Barras, David
Publicado: (2015)

Molecular Pattern and Clinical Implications of KRAS/NRAS and BRAF Mutations in Colorectal Cancer
por: Gökmen, İvo, et al.
Publicado: (2023)

Mutated DNA Damage Repair Pathways Are Prognostic and Chemosensitivity Markers for Resected Colorectal Cancer Liver Metastases
por: Wang, Kun, et al.
Publicado: (2021)

The significance of BRAF V600E mutation status discordance between primary cutaneous melanoma and brain metastases: The implications for BRAF inhibitor therapy
por: Hannan, Enda J., et al.
Publicado: (2017)

Effective MAPK Inhibition is critical for therapeutic responses in colorectal cancer with BRAF mutations
por: Ahronian, Leanne G., et al.
Publicado: (2015)

BRAF V600E potentially determines “Oncological Resectability” for “Technically Resectable” colorectal liver metastases
por: Kobayashi, Shin, et al.
Publicado: (2021)

Development of small-molecule therapeutics and strategies for targeting RAF kinase in BRAF-mutant colorectal cancer
por: Pan, Jing-hua, et al.
Publicado: (2018)

Explainable vs. interpretable artificial intelligence frameworks in oncology
por: Bertsimas, Dimitris, et al.
Publicado: (2023)

BRAF and NRAS Mutations in Papillary Thyroid Carcinoma and Concordance in BRAF Mutations Between Primary and Corresponding Lymph Node Metastases
por: Fakhruddin, Najla, et al.
Publicado: (2017)

Identification of prognostic inflammatory factors in colorectal liver metastases
por: Hamilton, Trevor D, et al.
Publicado: (2014)

Prognostic circulating proteomic biomarkers in colorectal liver metastases
por: Kim, Dongchan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_orfipecotnuqds1lai8qd38st6